Start-Up Spotlight: Genetesis, Developing A Stethescope For Heart’s Electrical Activity
Executive Summary
Genetesis raised $1.2m in seed funding last year to advance development of its noninvasive, radiation-free tool to map the heart’s electrical activity and enable detection of any cardiac abnormalities. The company will initially market the technology for use in chest pain triage in the emergency room.